Medical cannabis reform is at a critical juncture in Australia. The TGA (Therapeutic Goods Administration) recently finalised its open submission, posing 29 pivotal questions that will shape the future of access, quality, and patient care.In this episode, Chad details OnTracka's official submission in the interest of transparency. We reveal our data-driven responses to these crucial questions, covering major topics that will define the industry's direction for years to come.Join us to understand the arguments currently shaping medical cannabis policy.
What happens when you take an extended break from THC? In this episode, Chad shares his personal 30-day reset experience, comparing CBD (60–80mg) with prior THC use and reflecting on what’s changed since he started doing these annual resets back in 2018.We cover:Symptom relief on CBD vs THCLonger onset and therapeutic window with CBDReduced cravings and stress spikes compared to earlier breaksObserved differences in muscle soreness, sleep, and recoveryA hypothesis around THC’s role in rest, repair, and parasympathetic activityLessons for patients, clinicians, and anyone curious about cannabinoid use⚠️ This is not medical advice. These are individual learnings shared to help spark conversation and support evidence-based discussion.👉 Watch until the end for Chad’s conclusion on why he’ll continue CBD instead of returning to THC for now.Subscribe to stay updated on conversations that inspire higher living, deeper health, and conscious transformation.
Episode 50 is here, and we're discussing this one into the latest AHPRA guidelines on medical cannabis in Australia. 🤔 This has been an ongoing conversation in the industry, with concerns raised around prescribing practices, data transparency, and patient safety.We break down what these new restrictions mean for prescribers and challenge the call for more data from the regulator itself. We also tackle the sometimes contentious topic of cannabis dependence and addiction, advocating for a balanced, evidence-based approach to patient care.Join us as we explore why leading with data is crucial for the future of medical cannabis in healthcare, and why clinics with robust systems should be stepping up to lead the way. Interested in learning more about OnTracka?EMAIL: info@ontracka.comINSTAGRAM: @OnTrackaAppX/TWITTER: @OnTrackaAppDownload the OnTracka app:AppleGoogle Play#ahpra #MedicalCannabis #Australia #healthcarebusiness
In this episode of Higher Living, Chad dives into the rising buzz around clinics in Australia’s changing healthcare space. It’s been a big week of news, with Incannex Healthcare announcing a joint venture with Mind Medicine Australia, and Emyria landing a funding deal with Medibank. Clinics are back in the spotlight. But if they’re not turning a profit, why is everyone so eager to build or support them?
From CDA Clinics and Montu to Eucalyptus and their proprietary tech, we take a closer look at what’s really driving the boom. Is it the prescriptions? The patient services? Or is it all about the strategy?
Chad also breaks down two key models of vertical integration: owning the medications, or partnering with multiple suppliers. Each approach has major implications for patient access and long-term clinic sustainability.
So, is there actually money in clinics or are we missing something bigger?
What if everything you thought about health was missing one key ingredient?In this episode, Chad sits down with Jodi Duval, a naturopath, clinical educator, and leader in integrative medicine for a deep dive into the emerging science behind personalised wellness, preventative care, and what it really means to shift the needle on health.From cannabinoids to mitochondria, spirituality to science, and everything in between, this conversation opens doors to a whole new way of thinking about longevity, energy, and healing.Guest: Jodi Duval – Founder of Revital Health
Tegan Scates, the founder of Bloomly, is back and better than ever! They discuss the importance of women in the cannabis industry, the need for personalised treatment plans, and the potential of different consumption methods. Tegan shares her insights on the challenges and opportunities in the industry and her vision for a more inclusive and patient-centered approach to medical cannabis.
In this episode, Chad discuss the recent tragic death of a patient and the implications for the future of the cannabis industry in Australia. He explores the importance of transparency, regulation, and ethical practices to ensure the safety and well-being of patients. This episode is sensitive in nature and discusses a tragic event. Viewer discretion is advised
In this episode, guest Harry shared his experience in the cannabis industry and how the cannabis consumption landscape is not only changing-from concentrates being on the rise to personalized approaches.
On this episode, Chad talks about his experience using Telehealth for his appointments and explores the future of telehealth in healthcare. Despite its convenience, telehealth faces challenges in integration with traditional healthcare systems. Chad discusses the need for collaboration between patients, doctors, and government regulators to ensure a seamless transition to a digital future. Join the conversation by clicking here to complete the six questions: https://tally.so/r/w5LJVN
Australian authorities are investigating top cannabis doctors, but many patients remain unaware. This episode of Higher Living dives into the potential impact on patients' access to medical marijuana and questions the industry's transparency. Chad also explore the future of cannabis regulation in Australia.
This episode of Higher Living breaks down costs for medical cannabis patients in Australia, offering tips to potentially save money. The episode also explores the impact of cannabis on young people (based on a US study) before diving into Culture Corner where the show highlights what is happening in Germany where fans are being encouraged to use cannabis over alcohol.
This episode of Higher Living exposes the misleading hype and calls for informed advocacy. Hold politicians and media accountable for realistic timelines. Applaud patient heroes like Alice who bravely fight for their rights. Advocate for faster research and policy changes. Remember, this isn't just an Australian issue. Educate yourself, and support companies that prioritize patient needs over profit. Don't get lost in the news cycle. Demand faster action for responsible cannabis use!
Struggling with procrastination and can't stay focused or get things done? EP 36 explores using cannabis as a tool to combat procrastination while enhancing focus and concentration. Disclaimer: This episode explores responsible cannabis use. Consult a healthcare professional before making changes to your routine.
It's 420! But is cannabis truly free? In this episode, Chad dive into the origins of 4/20 and the current state of cannabis in 2024. He celebrate the vibrant culture but also expose the harsh realities. Join the conversation! It's time to celebrate responsibly and advocate for a freer future with cannabis.
Is the Australian Medicinal Cannabis Industry Under Threat? Australia's medicinal cannabis industry faces fresh criticism from the Australian Medical Association (AMA) and the Royal Australian College of General Practitioners (RACGP). In this weeks episode, Chad have present a clear message for patients, prescribers, and the industry that should trigger warnings about what could happen next.
In this episode, Chad delve into a crucial aspect of healthcare: patient advocacy. Join as he uncover the hidden agendas and influences shaping your healthcare decisions and how you can assert your role as an agent of change in your own well-being.
Join Chad to explore ethics in the evolving landscape of Cannabis and Psychedelic Medicines by offering perspective on the following points : 1. Ethics in the Australian Market 2. Navigating Industry Kickbacks 3. Dr. Ben Sessa's Recent Suspension 4. Community Response to Andrew Tate 5. Seth Rogen: A Cannabis Advocate's Journey
In this episode, Chad dives deep into the world of Women's Health and the Endocannabinoid System with the esteemed Michelle Sexton, N.D. With over a decade of clinical expertise, Michelle shares invaluable insights across the lifespan.
In this episode of Higher Living, Chad explores the potential of CBD flower as a lower-dose alternative in the Australian market. This episode gives you an overview about 1. Who could benefit from CBD Flower. 2. Breakdown of existing market trends from the Therapeutic Goods Administration of Australia. 3. Top medical conditions for CBD Flower. 4. Laws, legalities and loopholes. 5. Critical analysis of Vaping Nicotine and how CBD Flower could be an alternative.
This episode of Higher Living dives into the challenges and opportunities surrounding cannabis use in various professional settings. This episode is relevant to: Employees and employers Cannabis users and advocates Healthcare professionals Policymakers Anyone interested in the future of work.
